Literature DB >> 25088202

WEE1 murine deficiency induces hyper-activation of APC/C and results in genomic instability and carcinogenesis.

A Vassilopoulos1, Y Tominaga2, H-Seok Kim3, T Lahusen2, B Li4, H Yu4, D Gius5, C-X Deng2.   

Abstract

The tyrosine kinase WEE1 controls the timing of entry into mitosis in eukaryotes and its genetic deletion leads to pre-implantation lethality in mice. Here, we show that besides the premature mitotic entry phenotype, Wee1 mutant murine cells fail to complete mitosis properly and exhibit several additional defects that contribute to the deregulation of mitosis, allowing mutant cells to progress through mitosis at the expense of genomic integrity. WEE1 interacts with the anaphase promoting complex, functioning as a negative regulator, and the deletion of Wee1 results in hyper-activation of this complex. Mammary specific knockout mice overcome the DNA damage response pathway triggered by the mis-coordination of the cell cycle in mammary epithelial cells and heterozygote mice spontaneously develop mammary tumors. Thus, WEE1 functions as a haploinsufficient tumor suppressor that coordinates distinct cell division events to allow correct segregation of genetic information into daughter cells and maintain genome integrity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25088202      PMCID: PMC5547996          DOI: 10.1038/onc.2014.239

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  59 in total

1.  Genetic control of cell size at cell division in yeast.

Authors:  P Nurse
Journal:  Nature       Date:  1975-08-14       Impact factor: 49.962

Review 2.  Cell-cycle checkpoints and cancer.

Authors:  Michael B Kastan; Jiri Bartek
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

3.  The cdc25 protein contains an intrinsic phosphatase activity.

Authors:  W G Dunphy; A Kumagai
Journal:  Cell       Date:  1991-10-04       Impact factor: 41.582

4.  SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity.

Authors:  Hyun-Seok Kim; Athanassios Vassilopoulos; Rui-Hong Wang; Tyler Lahusen; Zhen Xiao; Xiaoling Xu; Cuiling Li; Timothy D Veenstra; Bing Li; Hongtao Yu; Junfang Ji; Xin Wei Wang; Seong-Hoon Park; Yong I Cha; David Gius; Chu-Xia Deng
Journal:  Cancer Cell       Date:  2011-10-18       Impact factor: 31.743

Review 5.  G2 checkpoint abrogators as anticancer drugs.

Authors:  Takumi Kawabe
Journal:  Mol Cancer Ther       Date:  2004-04       Impact factor: 6.261

6.  Human wee1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated Cdc2 kinase.

Authors:  R Heald; M McLoughlin; F McKeon
Journal:  Cell       Date:  1993-08-13       Impact factor: 41.582

7.  Polo-like kinase 1 (Plk1) in non-melanoma skin cancers.

Authors:  Travis L Schmit; Weixiong Zhong; Minakshi Nihal; Nihal Ahmad
Journal:  Cell Cycle       Date:  2009-09-02       Impact factor: 4.534

8.  The ubiquitin ligase APC(Cdh1) is required to maintain genome integrity in primary human cells.

Authors:  D Engelbert; D Schnerch; A Baumgarten; R Wäsch
Journal:  Oncogene       Date:  2007-08-13       Impact factor: 9.867

9.  Genomic stability and tumour suppression by the APC/C cofactor Cdh1.

Authors:  Irene García-Higuera; Eusebio Manchado; Pierre Dubus; Marta Cañamero; Juan Méndez; Sergio Moreno; Marcos Malumbres
Journal:  Nat Cell Biol       Date:  2008-06-15       Impact factor: 28.824

10.  Integrated functional, gene expression and genomic analysis for the identification of cancer targets.

Authors:  Elizabeth Iorns; Christopher J Lord; Anita Grigoriadis; Sarah McDonald; Kerry Fenwick; Alan Mackay; Charles A Mein; Rachael Natrajan; Kay Savage; Narinder Tamber; Jorge S Reis-Filho; Nicholas C Turner; Alan Ashworth
Journal:  PLoS One       Date:  2009-04-09       Impact factor: 3.240

View more
  12 in total

Review 1.  Cell cycle proteins as promising targets in cancer therapy.

Authors:  Tobias Otto; Piotr Sicinski
Journal:  Nat Rev Cancer       Date:  2017-01-27       Impact factor: 60.716

2.  METTL3 Regulates Liver Homeostasis, Hepatocyte Ploidy, and Circadian Rhythm-Controlled Gene Expression in Mice.

Authors:  Juan M Barajas; Cho-Hao Lin; Hui-Lung Sun; Frances Alencastro; Allen C Zhu; Mona Aljuhani; Ladan Navari; Selen A Yilmaz; Lianbo Yu; Kara Corps; Chuan He; Andrew W Duncan; Kalpana Ghoshal
Journal:  Am J Pathol       Date:  2021-09-29       Impact factor: 4.307

3.  Suppression of Sirt1 sensitizes lung cancer cells to WEE1 inhibitor MK-1775-induced DNA damage and apoptosis.

Authors:  G Chen; B Zhang; H Xu; Y Sun; Y Shi; Y Luo; H Jia; F Wang
Journal:  Oncogene       Date:  2017-09-04       Impact factor: 9.867

4.  Growth-Dependent Activation of Protein Kinases Suggests a Mechanism for Measuring Cell Growth.

Authors:  Akshi Jasani; Tiffany Huynh; Douglas R Kellogg
Journal:  Genetics       Date:  2020-05-27       Impact factor: 4.562

5.  Prolonged mitotic arrest induced by Wee1 inhibition sensitizes breast cancer cells to paclitaxel.

Authors:  Cody W Lewis; Zhigang Jin; Dawn Macdonald; Wenya Wei; Xu Jing Qian; Won Shik Choi; Ruicen He; Xuejun Sun; Gordon Chan
Journal:  Oncotarget       Date:  2017-05-13

6.  WEE1 inhibition targets cell cycle checkpoints for triple negative breast cancers to overcome cisplatin resistance.

Authors:  Hongping Zheng; Fangyuan Shao; Scots Martin; Xiaoling Xu; Chu-Xia Deng
Journal:  Sci Rep       Date:  2017-03-06       Impact factor: 4.379

7.  The RepID-CRL4 ubiquitin ligase complex regulates metaphase to anaphase transition via BUB3 degradation.

Authors:  Sang-Min Jang; Jenny F Nathans; Haiqing Fu; Christophe E Redon; Lisa M Jenkins; Bhushan L Thakur; Lőrinc S Pongor; Adrian M Baris; Jacob M Gross; Maura J OʹNeill; Fred E Indig; Steven D Cappell; Mirit I Aladjem
Journal:  Nat Commun       Date:  2020-01-07       Impact factor: 14.919

Review 8.  Targeting Non-Oncogene Addiction for Cancer Therapy.

Authors:  Hae Ryung Chang; Eunyoung Jung; Soobin Cho; Young-Jun Jeon; Yonghwan Kim
Journal:  Biomolecules       Date:  2021-01-20

Review 9.  A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target.

Authors:  Andrea Ghelli Luserna di Rorà; Claudio Cerchione; Giovanni Martinelli; Giorgia Simonetti
Journal:  J Hematol Oncol       Date:  2020-09-21       Impact factor: 17.388

Review 10.  Regulation of cell cycle drivers by Cullin-RING ubiquitin ligases.

Authors:  Sang-Min Jang; Christophe E Redon; Bhushan L Thakur; Meriam K Bahta; Mirit I Aladjem
Journal:  Exp Mol Med       Date:  2020-10-02       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.